✦ LIBER ✦

Preclinical modeling, dosiivietry, and clinical results of radioimmunoglobulin therapy

✍ Scribed by Stanley E. Order; Jerry L. Klein; Peter K. Leichner

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 103 KB
Volume: 21
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(91)90396-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical modeling, dosimetry, and cli

Preclinical modeling, dosimetry, and clinical results of radioimmunoglobulin therapy

✍ Stanley E. Order; Jerry L. Klein; Peter K. Leichner 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Nasopharyngeal carcinoma: Clinical cours

Nasopharyngeal carcinoma: Clinical course and results of therapy

✍ Baker, Shan R. 📂 Article 📅 1980 🏛 Wiley (John Wiley & Sons) ⚖ 551 KB

## Abstract Ninety‐nine patients with carcinoma of the nasopharynx were reviewed. No significant relationship was found between T classification and survival or between tumor cell type and survival. The presence of regional metastases, however, did influence the outcome of therapy. A 5‐year surviva

Preclinical and Clinical Practice of Low

Preclinical and Clinical Practice of Low-Dose FP Therapy in Japan: Japanese Use of Low-Dose FP Therapy

✍ Tetsuhiko Shirasaka; Akihito Tsuji; Susumu Yamamitsu; Tetsuo Taguchi 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB 👁 1 views

Nasopharyngeal carcinoma in Taiwan clini

Nasopharyngeal carcinoma in Taiwan clinical manifestations and results of therapy

✍ Mow-Ming Hsu; Shih-Mien Tu 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

A retrospective study was performed on 966 patients with histologically verified nasopharyngeal carcinomas. The follow-up rate was 93.6% over a minimum period of five years. The actuarial and relapsefree survivals were 82% and 49% at one year, 64% and 43% at two years, 43% and 33% at five years, and

Clinical evaluation of neutron beam ther

Clinical evaluation of neutron beam therapy. Current results and prospects, 1983

✍ Lionel Cohen; Frank R. Hendrickson; Parvathy D. Kurup; Jo Anne Mansell; Miguel A 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

Modeling of congenital erythropoietic po

Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation

✍ Elodie Robert-Richard; Magalie Lalanne; Isabelle Lamrissi-Garcia; Véronique Guyo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

## Abstract ## Background Congenital erythropoietic porphyria (CEP) is a severe autosomal recessive disorder characterized by a deficiency in uroporphyrinogen III synthase (UROS), the fourth enzyme of the heme biosynthetic pathway. We recently demonstrated the definitive cure of a murine model of